| Indicators | Browse All

Amarin Corporation plc (AMRN)

Healthcare | Drug Manufacturers - General | Dublin, Ireland | NasdaqCM
13.97 USD -0.10 (-0.711%) ⇩ (Aug. 28, 2026, 4 p.m. EDT)
After hours: 13.97

Short-term:★★⯪☆☆Long-term:★☆☆☆☆Dividends:☆☆☆☆☆
Hot Take | Aug. 22, 2026, 4:17 a.m. EDT

The long-term outlook remains deeply concerning due to a brutal multi-year decline where the stock has lost nearly 75% of its value over nine years, with seven consecutive years of negative annual returns. Despite a recent bounce, the business fundamentals are deteriorating sharply: revenues have contracted by 42%, operating margins are negative at -28%, and the company is burning cash with negative free flow. The balance sheet, while currently liquid, cannot sustain this operational bleed indefinitely. The short-term chart shows a fragile recovery off multi-year lows, but the lack of earnings power and the heavy speculative put positioning suggest this rally lacks a sustainable foundation. With no dividend to provide income and a massive gap between the current price and the analyst consensus target of $12, the investment case is weak.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoARIMA ✓0.051238
AutoTheta0.051805
AutoETS0.052373
MSTL0.053762

Forecast horizon: 45 days | Selected: AutoARIMA

Forecast Reliability
Score 63%
H-stat 0.56
Ljung-Box p 0.000
Jarque-Bera p 0.210
Excess Kurtosis -1.18
Attribute Value
Sector Healthcare
Debt to Equity Ratio 1.617
Revenue per Share 8.917
Market Cap 292,938,432
Forward P/E 14.26
Beta 0.77
Profit Margins -14.56%
Website https://www.amarincorp.com

As of Aug. 22, 2026, 4:17 a.m. EDT: Speculators are positioning defensively with heavy out-of-the-money put open interest at strikes significantly below current price (e.g., $6 and $13), suggesting a fear of a sharp decline or a 'crash' scenario. Conversely, call activity is sparse and concentrated at distant strikes ($20-$30), indicating a lack of immediate bullish conviction despite the recent price recovery.


Info Dump

Attribute Value
52 Week Change -0.079710126
Address1 One Central Plaza
Address2 8th Floor 36 Dame Street
All Time High 28,500.0
All Time Low 7.0
Ask 15.99
Ask Size 1
Average Analyst Rating 4.5 - Underperform
Average Daily Volume10 Day 117,060
Average Daily Volume3 Month 84,750
Average Volume 84,750
Average Volume10Days 117,060
Beta 0.765
Bid 11.99
Bid Size 1
Book Value 21.122
City Dublin
Compensation As Of Epoch Date 1,767,139,200
Country Ireland
Crypto Tradeable 0
Currency USD
Current Price 13.97
Current Ratio 3.671
Custom Price Alert Confidence HIGH
Date Short Interest 1,786,665,600
Day High 14.9
Day Low 13.89
Debt To Equity 1.617
Display Name Amarin
Earnings Call Timestamp End 1,785,326,400
Earnings Call Timestamp Start 1,785,326,400
Earnings Timestamp 1,785,328,200
Earnings Timestamp End 1,793,190,600
Earnings Timestamp Start 1,793,190,600
Ebitda -21,095,000
Ebitda Margins -0.11327
Enterprise To Ebitda 0.587
Enterprise To Revenue -0.067
Enterprise Value -12,388,009
Eps Forward 0.98
Eps Trailing Twelve Months -1.2
Esg Populated 0
Exchange NCM
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 14.6208
Fifty Day Average Change -0.65079975
Fifty Day Average Change Percent -0.04451191
Fifty Two Week Change Percent -7.9710126
Fifty Two Week High 20.9
Fifty Two Week High Change -6.9299994
Fifty Two Week High Change Percent -0.3315789
Fifty Two Week Low 12.96
Fifty Two Week Low Change 1.0100002
Fifty Two Week Low Change Percent 0.07793212
Fifty Two Week Range 12.96 - 20.9
Financial Currency USD
First Trade Date Milliseconds 733,674,600,000
Float Shares 19,026,181
Forward Eps 0.98
Forward P E 14.255102
Free Cashflow -5,569,250
Full Exchange Name NasdaqCM
Full Time Employees 80
Fullday Change -0.0999994
Fullday Change Percent -0.710728
Fullday Price 13.97
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.41956002
Gross Profits 78,136,000
Has Pre Post Market Data 1
Held Percent Insiders 0.37171
Held Percent Institutions 0.22489001
Implied Shares Outstanding 20,969,109
Industry Drug Manufacturers - General
Industry Disp Drug Manufacturers - General
Industry Key drug-manufacturers-general
Ir Website http://investor.amarincorp.com/
Is Earnings Date Estimate 1
Language en-US
Last Fiscal Year End 1,767,139,200
Last Split Date 1,744,329,600
Last Split Factor 1:20
Long Business Summary Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally through wholesalers, selected regional wholesalers, and retail and mail order pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.
Long Name Amarin Corporation plc
Market us_market
Market Cap 292,938,432
Market State CLOSED
Max Age 86,400
Message Board Id finmb_407863
Most Recent Quarter 1,782,777,600
Net Income To Common -27,124,000
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 295,978,971
Number Of Analyst Opinions 2
Open 14.15
Operating Cashflow 15,573,000
Operating Margins -0.28358
Payout Ratio 0.0
Peg Ratio 0.81
Phone 353 0 166 99020
Post Market Change 0.0
Post Market Change Percent 0.0
Post Market Price 13.97
Post Market Time 1,787,959,805
Previous Close 14.07
Price Hint 2
Price To Book 0.6613957
Price To Sales Trailing12 Months 1.5729674
Profit Margins -0.14565
Quick Ratio 2.491
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key underperform
Recommendation Mean 4.5
Region US
Regular Market Change -0.0999994
Regular Market Change Percent -0.710728
Regular Market Day High 14.9
Regular Market Day Low 13.89
Regular Market Day Range 13.89 - 14.9
Regular Market Open 14.15
Regular Market Previous Close 14.07
Regular Market Price 13.97
Regular Market Time 1,787,947,201
Regular Market Volume 78,194
Return On Assets -0.023120001
Return On Equity -0.059710003
Revenue Growth -0.42
Revenue Per Share 8.917
Sand P52 Week Change 0.20204377
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Shares Outstanding 20,969,109
Shares Percent Shares Out 0.0249
Shares Short 525,685
Shares Short Previous Month Date 1,784,073,600
Shares Short Prior Month 513,202
Short Name Amarin Corporation plc
Short Percent Of Float 0.0254
Short Ratio 9.59
Source Interval 15
Symbol AMRN
Target High Price 13.0
Target Low Price 12.0
Target Mean Price 12.5
Target Median Price 12.5
Total Cash 314,648,992
Total Cash Per Share 14.896
Total Debt 7,175,000
Total Revenue 186,232,992
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -1.2
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 14.8075
Two Hundred Day Average Change -0.8374996
Two Hundred Day Average Change Percent -0.05655915
Type Disp Equity
Volume 78,194
Website https://www.amarincorp.com
Zip D02 K7K5